Moisand Fitzgerald Tamayo’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.83K | Hold |
13
| – | – | ﹤0.01% | 383 |
|
|
2025
Q1 | $8.25K | Hold |
13
| – | – | ﹤0.01% | 362 |
|
|
2024
Q4 | $9.26K | Hold |
13
| – | – | ﹤0.01% | 350 |
|
|
2024
Q3 | $13.7K | Hold |
13
| – | – | ﹤0.01% | 323 |
|
|
2024
Q2 | $13.7K | Hold |
13
| – | – | ﹤0.01% | 281 |
|
|
2024
Q1 | $12.5K | Hold |
13
| – | – | ﹤0.01% | 291 |
|
|
2023
Q4 | $11.4K | Hold |
13
| – | – | ﹤0.01% | 320 |
|
|
2023
Q3 | $10.7K | Hold |
13
| – | – | ﹤0.01% | 329 |
|
|
2023
Q2 | $9.34K | Hold |
13
| – | – | ﹤0.01% | 327 |
|
|
2023
Q1 | $10.7K | Hold |
13
| – | – | ﹤0.01% | 324 |
|
|
2022
Q4 | $9.38K | Buy |
13
+7
| +117% | +$5.05K | ﹤0.01% | 326 |
|
|
2022
Q3 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 410 |
|
|
2017
Q4 | – | Sell |
-5
| Closed | -$2K | – | 310 |
|
|
2017
Q3 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 284 |
|